WegovyvsMounjaro
Both are GLP-1 receptor agonist • Side-by-side comparison
Wegovy vs Mounjaro: Overview
Wegovy and Mounjaro are both prescription medications used in clinical practice. Both Wegovy and Mounjaro belong to the GLP-1 receptor agonist drug class and work through similar mechanisms. Wegovy is commonly used for Weight loss, while Mounjaro is used for Type 2 diabetes, Weight loss. They differ in their active ingredients and may have different side effect profiles, dosing schedules, and drug interactions. As with all medications, your doctor will determine which is most appropriate based on your medical history, other medications, and specific health goals.
Key Facts at a Glance
- ✓Same drug class: GLP-1 receptor agonist
- ✓Wegovy used for: Weight loss
- ✓Mounjaro used for: Type 2 diabetes, Weight loss
- ✓Different active ingredients
- ✓Consult your doctor before switching between these medications
- ✓Individual response, tolerability, and cost affect the best choice
Wegovy
Drug AUsed For
- ✓ Weight loss
Mounjaro
Drug BUsed For
- ✓ Type 2 diabetes
- ✓ Weight loss
Key Differences
Which Should You Choose?
The best choice between Wegovy and Mounjaro depends on your specific diagnosis, medical history, other medications, and individual response to treatment. Since both are GLP-1 receptor agonist medications, your doctor may try one before the other based on your profile. Always work with your healthcare provider to find the medication that gives you the best results with the fewest side effects.